|

[177Lu]Lu-DWJ155 Clinical Trials

1 actively recruiting trial

Also known as: FML539

Pipeline

Phase 1: 1

Top Sponsors

  • Novartis Pharmaceuticals1

Indications

  • Gastric/Gastroesophageal Junction (GEJ) Cancer1
  • Non-small Cell Lung Cancer (NSCLC)1
  • Bladder Cancer1
  • Lung Cancer1
  • Breast Cancer1

Other1 trial

Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.